Summary:
«HotSpot Therapeutics, the allostery-focused biotech that works on what it calls “natural hotspots” — hence the name — is getting a bit hotter in its valuation from investors. And to that end they’ve raised $100 million.»
Article written by Paul Schloesser
29|11|2021
Source:
EndpointsNews
https://endpts.com/hotspot-gets-hotter-with-100m-raise-to-push-toward-clinic/